NovMetaPharma Co., Ltd. (XKON:229500)
5,190.00
+150.00 (2.98%)
At close: Aug 11, 2026
-65.26% (1Y)
| Market Cap | 66.65B -63.2% |
| Revenue (ttm) | 1.30B +21.4% |
| Net Income | 408.03M |
| EPS | 120.00 |
| Shares Out | 12.84M |
| PE Ratio | 43.25 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 537 |
| Open | 5,100.00 |
| Previous Close | 5,040.00 |
| Day's Range | 4,805.00 - 5,350.00 |
| 52-Week Range | 3,905.00 - 16,950.00 |
| Beta | 0.16 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |